Oliver Treacy

1.6k citations

26 papers · 1.1k indexed · h-index 16

Impact in

Genetics top 1%
- Mesenchymal stem cell research
Transplantation top 10%

Papers in

Genetics 15
- Mesenchymal stem cell research 15
Immunology 9
- Immunotherapy and Immune Responses 6
- T-cell and B-cell Immunology 3

Co-authors: Thomas Ritter Aideen E. Ryan Paul Lohan Matthew D. Griffin Lisa O’Flynn Mary Murphy Frank Barry Georgina Shaw
Journals: Molecular Therapy (3 papers)Frontiers in Immunology (3 papers)The FASEB Journal (2 papers)American Journal of Transplantation (2 papers)Stem Cell Research & Therapy (2 papers)
Partner nations: Ireland Mexico United Kingdom

In The Last Decade

Oliver Treacy

25 papers receiving 1.1k citations

Peers

Countries citing papers authored by Oliver Treacy

Since Specialization

Citations

This map shows the geographic impact of Oliver Treacy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Treacy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Treacy more than expected).

Fields of papers citing papers by Oliver Treacy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Treacy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Treacy. The network helps show where Oliver Treacy may publish in the future.

Co-authors

The 25 scholars most cited alongside Oliver Treacy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Oliver Treacy Line = papers co-authored together Oliver Treacy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Small extracellular vesicles secreted from TGF-β1-licensed mesenchymal stromal cells reduce inflammation-associated injury following corneal alkali burn Stem Cell Research & Therapy ·Fritzi Wiessmann, Christopher R. Schulz, Edward W. Johnston, Minghau Wang, Jiemin Wang, Martin J. Leahy, Oliver Treacy, Aideen E. Ryan, Thomas Ritter	2025	0
2	The Tumour Glyco‐Code: Sialylation as a Mediator of Stromal Cell Immunosuppression in the Tumour Microenvironment European Journal of Immunology ·Amriddin E. Berdimurarov, Norashikin Zakaria, YANG Chen, Oliver Treacy, Aisling Hogan, Michael O’Dwyer, Seán O. Hynes, Aideen E. Ryan	2025	1
3	Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signaling iScience ·Niamh Leonard, А. С. Беркос, 臨時行政改革推進審議会, YANG Chen, Grace O’Malley, Kerry Thompson, Alessio Amicone, Amriddin E. Berdimurarov, Norashikin Zakaria, Laurence J. Egan, Thomas Ritter, Daniela Loessner, Keara L. Redmond, Mary C. Sheehan, Aoife Canney, Aisling Hogan, Seán O. Hynes, Oliver Treacy, Philip D. Dunne, Aideen E. Ryan	2024	8
4	A 3D View of Colorectal Cancer Models in Predicting Therapeutic Responses and Resistance Cancers ·臨時行政改革推進審議会, Niamh Leonard, Oliver Treacy, Aideen E. Ryan	2021	61
5	Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice Stem Cell Research & Therapy ·Oliver Treacy, Kevin Lynch, Nick Murphy, Xizhe Chen, Fritzi Wiessmann, Christopher R. Schulz, Paul Lohan, Georgina Shaw, 黄文德, Aideen E. Ryan, Thomas Ritter	2021	8
6	Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosis OncoImmunology ·Schell Kh, ML Menendez Lopez-Mateos, Kevin Lynch, Dawn Swan, Inga Wiehl, Robert B. Henderson, Niamh Leonard, Oliver Treacy, Alessandro Natoni, Dajung, Joana Cabral, Christopher Chiu, Kate Sasser, Thomas Ritter, Michael O’Dwyer, Aideen E. Ryan	2021	13
7	TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo Molecular Therapy ·Kevin Lynch, Oliver Treacy, Xizhe Chen, Nick Murphy, Paul Lohan, Md Nahidul Islam, Fritzi Wiessmann, Matthew D. Griffin, Luke Watson, K BULTE, Grace O’Malley, Aideen E. Ryan, Thomas Ritter	2020	52
8	Stromal Cell PD-L1 Inhibits CD8+ T-cell Antitumor Immune Responses and Promotes Colon Cancer Cancer Immunology Research ·Grace O’Malley, Oliver Treacy, Kevin Lynch, Schell Kh, Niamh Leonard, Paul Lohan, Philip D. Dunne, Thomas Ritter, Laurence J. Egan, Aideen E. Ryan	2018	68
9	Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation Frontiers in Immunology ·Paul Lohan, Nick Murphy, Oliver Treacy, Kevin Lynch, 朱云周 Zhu Yunzhou, Zuxing Zhang, Aideen E. Ryan, Matthew D. Griffin, Thomas Ritter	2018	44
10	Interspecies Incompatibilities Limit the Immunomodulatory Effect of Human Mesenchymal Stromal Cells in the Rat Stem Cells ·Paul Lohan, Oliver Treacy, 朱云周 Zhu Yunzhou, Fritzi Wiessmann, Elena Martín-Díaz, Aideen E. Ryan, Stephen J. Elliman, Thomas Ritter, Matthew D. Griffin	2018	22
11	Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning? Frontiers in Immunology ·Paul Lohan, Oliver Treacy, Matthew D. Griffin, Thomas Ritter, Aideen E. Ryan	2017	117
12	Regulating Immunogenicity and Tolerogenicity of Bone Marrow-Derived Dendritic Cells through Modulation of Cell Surface Glycosylation by Dexamethasone Treatment Frontiers in Immunology ·Kevin Lynch, Oliver Treacy, Jared Q. Gerlach, Heidi Annuk, Paul Lohan, Joana Cabral, Lokesh Joshi, Aideen E. Ryan, Thomas Ritter	2017	15
13	Mesenchymal stem cell therapy to promote corneal allograft survival Current Opinion in Organ Transplantation ·Nick Murphy, Kevin Lynch, Paul Lohan, Oliver Treacy, Thomas Ritter	2016	21
14	Culture expanded primary chondrocytes have potent immunomodulatory properties and do not induce an allogeneic immune response Osteoarthritis and Cartilage ·Paul Lohan, Oliver Treacy, Kevin Lynch, Frank Barry, Mary Murphy, Matthew D. Griffin, Thomas Ritter, Aideen E. Ryan	2015	26
15	Corneal Immunosuppressive Mechanisms, Anterior Chamber-Associated Immune Deviation (ACAID) and Their Role in Allograft Rejection Methods in molecular biology ·Oliver Treacy, 黄文德, Thomas Ritter, Lisa O’Flynn	2015	14
16	Mesenchymal Stem Cell Therapy Promotes Corneal Allograft Survival in Rats by Local and Systemic Immunomodulation American Journal of Transplantation ·Oliver Treacy, Lisa O’Flynn, Aideen E. Ryan, R. v. Hirsch, Paul Lohan, Sabine Schu, Mieszko M. Wilk, Ahmad Matarneh, Matthew D. Griffin, Taihao Shi, Thomas Ritter	2014	40
17	Donor Bone Marrow–derived Dendritic Cells Prolong Corneal Allograft Survival and Promote an Intragraft Immunoregulatory Milieu Molecular Therapy ·Lisa O’Flynn, Oliver Treacy, Aideen E. Ryan, 朱云周 Zhu Yunzhou, E.A. Yurkevich, Jared Q. Gerlach, Lokesh Joshi, Mikhail Nosov, Thomas Ritter	2013	10
18	Chondrogenic Differentiation Increases Antidonor Immune Response to Allogeneic Mesenchymal Stem Cell Transplantation Molecular Therapy ·Aideen E. Ryan, Paul Lohan, Lisa O’Flynn, Oliver Treacy, Xizhe Chen, Cynthia M. Coleman, Georgina Shaw, Mary Murphy, Frank Barry, Matthew D. Griffin, Thomas Ritter	2013	82
19	Adenoviral Transduction of Mesenchymal Stem Cells: In Vitro Responses and In Vivo Immune Responses after Cell Transplantation PLoS ONE ·Oliver Treacy, Aideen E. Ryan, D.H. Salare, Lisa O’Flynn, E.A. Yurkevich, Mieszko M. Wilk, Francesca Odoardi, Paul Lohan, Timothy O’Brien, Mikhail Nosov, Thomas Ritter	2012	33
20	Anti‐donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? Immunology and Cell Biology ·Matthew D. Griffin, Aideen E. Ryan, Senthilkumar Alagesan, Paul Lohan, Oliver Treacy, Thomas Ritter	2012	191

About Oliver Treacy

Oliver Treacy is a scholar working on Genetics, Immunology, Radiology, Nuclear Medicine and Imaging, Rehabilitation and Biotechnology, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (15 papers), Corneal Surgery and Treatments (9 papers), Tissue Engineering and Regenerative Medicine (7 papers), Immunotherapy and Immune Responses (6 papers), Extracellular vesicles in disease (5 papers), Cancer Cells and Metastasis (4 papers), Glycosylation and Glycoproteins Research (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Genetics (671 citations), Transplantation (31 citations), Urology (68 citations), Immunology (188 citations) and Rehabilitation (60 citations). Oliver Treacy has collaborated with scholars based in Ireland, Mexico and United Kingdom. Frequent co-authors include Thomas Ritter, Aideen E. Ryan, Paul Lohan, Matthew D. Griffin, Lisa O’Flynn, Mary Murphy, Frank Barry, Georgina Shaw, Senthilkumar Alagesan and Mikhail Nosov. Their work appears in journals such as Molecular Therapy, Frontiers in Immunology, The FASEB Journal, American Journal of Transplantation and Stem Cell Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact